You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Insulin degludec, insulin aspart drug combination

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Berne (GlucoTab, Insulin Degludec)

Completed
  • Type 2 Diabetes Mellitus
  • GlucoTab
  • Insulin Degludec
  • Berne, Switzerland
    Division of Endocrinology, Diabetes, Clinical Nutrition & Metabo
Apr 7, 2020

Type1diabetes Trial in New Haven (Aspart insulin)

Recruiting
  • Type1diabetes
  • Aspart insulin
  • New Haven, Connecticut
    Yale University School of Medicine
May 19, 2022

Type 1 Diabetes Trial in Atlanta, West Des Moines, Minneapolis (LY900014, Insulin Degludec)

Completed
Has Results
  • Type 1 Diabetes
  • Atlanta, Georgia
  • +2 more
May 6, 2022

Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Insulin glargine, 300 U/ml
  • +2 more
  • Dallas, Texas
  • +6 more
Oct 19, 2022

Diabetes, Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Recruiting
  • Diabetes
  • Type 2 Diabetes
  • Escondido, California
  • +128 more
Jan 18, 2023

Type 1 Diabetes Trial in New Orleans (Insulin Aspart, Insulin Lispro)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Insulin Aspart
  • Insulin Lispro
  • New Orleans, Louisiana
    Clinical Translational Unit - Tulane School of Medicine
Jan 6, 2021

Type 2 Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Active, not recruiting
  • Type 2 Diabetes
  • Little Rock, Arkansas
  • +129 more
Jan 19, 2023

Diabetes, Type 1 Trial in Graz (NNC0471-0119 A, NNC0471-0119 B, NNC0471-0119 D)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • NNC0471-0119 A
  • +3 more
  • Graz, Austria
    Novo Nordisk Investigational Site
Aug 15, 2022

Type 1 Diabetes, Diabetes Trial in Worldwide (LY3209590, Insulin Degludec)

Not yet recruiting
  • Type 1 Diabetes
  • Diabetes
  • Concord, California
  • +86 more
Aug 17, 2022

Diabetes, Type 2 Trial in Atlanta (Insulin glargine, Insulin aspart, Supplemental insulin aspart)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • +2 more
  • Atlanta, Georgia
  • +1 more
Dec 10, 2020

Type 1 Diabetes Trial in Montréal (Insulin FiAsp, Insulin Aspart, 60-minutes postprandial exercise)

Recruiting
  • Type 1 Diabetes Mellitus
  • Insulin FiAsp
  • +3 more
  • Montréal, Quebec, Canada
    Institut de recherches cliniques de Montréal
Mar 8, 2022

type1diabetes, Diabetes, Type 1 Trial in Montreal (Pramlintide, Insulin Lispro, Insulin aspart)

Not yet recruiting
  • type1diabetes
  • Diabetes Mellitus, Type 1
  • Montreal, Quebec, Canada
    Research Institute of the McGill University Health Center
Sep 18, 2023

Diabetes, Type 1 Trial in Chula Vista (AT247, NovoLog, Fiasp)

Active, not recruiting
  • Diabetes Mellitus, Type 1
  • Chula Vista, California
    ProSciento, Inc
Aug 12, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin Icodec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin Icodec
  • Buena Park, California
  • +71 more
Mar 29, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec/insulin aspart, Insulin glargine, Insulin aspart)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/insulin aspart
  • +2 more
  • Glendale, Arizona
  • +70 more
Nov 8, 2019

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Type 1 Diabetes-Type 2 Diabetes Trial in Worldwide (Insulin aspart, NovoLog/NovoRapid, Insulin glargine (HOE901))

Completed
Has Results
  • Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus
  • Insulin aspart
  • +2 more
  • Little Rock, Arkansas
  • +81 more
Mar 15, 2022

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the

Not yet recruiting
  • Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
  • +6 more
  • Chiglitazar sodium
  • Chiglitazar placebo
  • Guangzhou, Guangdong, China
    the First Affiliated Hospital of Sun Yat-sen University
Aug 17, 2023

Diabetes, Diabetes, Type 2 Trial in China, Hong Kong (Insulin degludec/liraglutide, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec/liraglutide
  • Insulin degludec
  • Hefei, Anhui, China
  • +36 more
Mar 18, 2020

Type 1 Diabetes Trial in Boston (Humalog, Novolog, BC222 insulin lispro)

Terminated
Has Results
  • Type 1 Diabetes Mellitus
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 10, 2022

Type 2 Diabetes Trial in China, Korea, Republic of, United States (Efpeglenatide SAR439977, Placebo, Background therapy)

Terminated
Has Results
  • Type 2 Diabetes Mellitus
  • Efpeglenatide SAR439977
  • +2 more
  • Birmingham, Alabama
  • +46 more
Nov 4, 2021

Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg

Not yet recruiting
  • Type2diabetes
  • Insulin Resistance
  • (no location specified)
Oct 20, 2022

Type 1 Diabetes Trial in Asheville (Faster Insulin Aspart (Fiasp®))

Recruiting
  • Type 1 Diabetes Mellitus
  • Faster Insulin Aspart (Fiasp®)
  • Asheville, North Carolina
    Mountain Diabetes and Endocrine Center
Nov 20, 2020

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Little Rock, Arkansas
  • +121 more
Jan 14, 2022

Diabetes, Diabetes, Type 1 Trial in Russian Federation (GP40071, NovoRapid® Penfill®)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Arkhangel'sk, Russian Federation
  • +13 more
Jul 21, 2020